FDA
approval
· 2020-07-30
FDA Approved: CAPTOPRIL AND HYDROCHLOROTHIAZIDE — Supplemental Application (Rising Pharma Holdings, Inc.)
Summary
FDA approved a supplemental application for CAPTOPRIL AND HYDROCHLOROTHIAZIDE (Rising Pharma Holdings, Inc.), a combination antihypertensive product containing …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for CAPTOPRIL AND HYDROCHLOROTHIAZIDE (CAPTOPRIL AND HYDROCHLOROTHIAZIDE)